← Open Payments lookup

EVELINE PAUL: Open Payments

NPI 1154097095 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$389 in 20 payments from 12 companies in 2025. Trend: 2023 $303 · 2024 $248 · 2025 $389

Food & beverage: $389
CompanyPaymentsAmount
Lilly USA, LLC4$76
Novo Nordisk Inc4$72
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$42
PFIZER INC.2$41
Sumitomo Pharma America, Inc.1$26
Abbott Laboratories1$25
Dexcom, Inc.1$24
Boehringer Ingelheim Pharmaceuticals, Inc.1$20
Esperion Therapeutics, Inc.1$17
Inspire Medical Systems, Inc.1$17

Products named: MOUNJARO, XIFAXAN, Ozempic, JARDIANCE, GEMTESA, FREESTYLE LIBRE 3, ELIQUIS, Dexcom G6 Transmitter.

Industry payments across SC — which companies pay providers there.